Canada markets closed

Ono Pharmaceutical Co., Ltd. (OPHLF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
14.740.00 (0.00%)
At close: 09:57AM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 6.93B
Enterprise Value 5.67B
Trailing P/E 8.60
Forward P/E 13.87
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.19
Price/Book (mrq)1.36
Enterprise Value/Revenue 0.03
Enterprise Value/EBITDA 0.08

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-27.29%
S&P500 52-Week Change 326.27%
52 Week High 320.28
52 Week Low 314.47
50-Day Moving Average 315.98
200-Day Moving Average 317.58

Share Statistics

Avg Vol (3 month) 3652
Avg Vol (10 day) 31.03k
Shares Outstanding 5469.65M
Implied Shares Outstanding 6470.04M
Float 8455.93M
% Held by Insiders 115.55%
% Held by Institutions 146.72%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.52
Forward Annual Dividend Yield 43.51%
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 430.01%
Dividend Date 3Jun 25, 2018
Ex-Dividend Date 4Sept 27, 2024
Last Split Factor 25:1
Last Split Date 3Mar 29, 2016

Financial Highlights

Currency in JPY.

Fiscal Year

Fiscal Year Ends Mar 31, 2024
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 25.46%
Operating Margin (ttm)13.58%

Management Effectiveness

Return on Assets (ttm)11.13%
Return on Equity (ttm)16.56%

Income Statement

Revenue (ttm)502.67B
Revenue Per Share (ttm)1,047.21
Quarterly Revenue Growth (yoy)4.30%
Gross Profit (ttm)N/A
EBITDA 178.07B
Net Income Avi to Common (ttm)127.98B
Diluted EPS (ttm)1.71
Quarterly Earnings Growth (yoy)2.10%

Balance Sheet

Total Cash (mrq)204.6B
Total Cash Per Share (mrq)433.14
Total Debt (mrq)8.86B
Total Debt/Equity (mrq)1.11%
Current Ratio (mrq)3.99
Book Value Per Share (mrq)1,678.75

Cash Flow Statement

Operating Cash Flow (ttm)110.66B
Levered Free Cash Flow (ttm)49.81B